Hunjoo Ha Professor Emeritus
Hunjoo Ha is Professor at College of Pharmacy/Graduate School of Pharmaceutical Sciences. She has received her Ph.D. in Pharmacology at University of Minnesota, Mpls., MN, USA. Her main research interest is to understand the mechanism involved in tissue fibrosis focused on the role of reactive oxygen species in diabetic kidney injury. She has published more than 100 SCI papers. She has served as Chair of Academic Committee of the Pharmaceutical Society of Korea and Editor-in-Chief of Korean Journal of Physiology & Pharmacology.
- Research Interests
Research Record
- AZD7648, a DNA-PKcs inhibitor, overcomes radioresistance in Hep3B xenografts and cells under tumor hypoxia AMERICAN JOURNAL OF CANCER RESEARCH, 2023, v.13 no.10, 4918-4930
- Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances Korean Journal of Physiology and Pharmacology, 2022, v.26 no.1, 1-13
- Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, v.54 no.8, 1086-1097
- Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non- Alcoholic Fatty Liver Disease in Mice DIABETES & METABOLISM JOURNAL, 2022, v.46 no.6, 829-842
- Activation of beta(2) adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases ARCHIVES OF PHARMACAL RESEARCH, 2021, v.44 no.1, 49-62
- Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice BIOMOLECULES, 2021, v.11 no.2, 322
- CO-Releasing Molecule-2 Prevents Acute Kidney Injury through Suppression of ROS-Fyn-ER Stress Signaling in Mouse Model OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, v.2021, 9947772
- Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk PHYTOMEDICINE, 2021, v.80, 153393
- Dual actions of a2a and a3 adenosine receptor ligand prevents obstruction-induced kidney fibrosis in mice International Journal of Molecular Sciences, 2021, v.22 no.11, 5667
- Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2 CELLS, 2021, v.10 no.12, 3306
- Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy Kidney International, 2021, v.99 no.2, 443-455
- Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster JOURNAL OF FOOD SCIENCE, 2021, v.86 no.11, 5016-5025
- KF-1607, a novel pan src kinase inhibitor, attenuates obstruction-induced tubulointerstitial fibrosis in mice Biomolecules and Therapeutics, 2021, v.29 no.1, 41-51
- Pharmacotherapy against oxidative stress in chronic kidney disease: Promising small molecule natural products targeting nrf2-ho-1 signaling Antioxidants, 2021, v.10 no.2, 1-26
- Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.15, 8258
- Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances Marine drugs, 2021, v.19 no.3, 0
- Protective Effects of Black Cumin (Nigella sativa) and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.16, 9078
- Evaluation of Anti-Tumor Effects of Whole-Body Low-Dose Irradiation in Metastatic Mouse Models CANCERS, 2020, v.12 no.5
- Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury BIOMOLECULES & THERAPEUTICS, 2020, v.28 no.3, 213-221
- Inhibition of src family kinases ameliorates lps-induced acute kidney injury and mitochondrial dysfunction in mice International Journal of Molecular Sciences, 2020, v.21 no.21, 1-17
- Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways FRONTIERS IN PHARMACOLOGY, 2020, v.11, 265
- The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress Free Radical Biology and Medicine, 2020, v.148, 22-32
- Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.23, 8969
- 성인지적 성건강의 융복합적 모형개발: 성인지 지표에 기반한 Sustainable Development Goals 국가와 북한과의 비교 연구 한국모자보건학회지, 2020, v.24 no.1, 40-51
- Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2019, v.471 no.6, 829-843
- Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway Cell Death and Disease, 2019, v.10 no.2, 78
- Cigarette smoke inhalation aggravates diabetic kidney injury in rats TOXICOLOGY RESEARCH, 2019, v.8 no.6, 964-971
- Correlation study between A(3) adenosine receptor binding affinity and anti-renal interstitial fibrosis activity of truncated adenosine derivatives ARCHIVES OF PHARMACAL RESEARCH, 2019, v.42 no.9, 773-779
- Enrichment of Short-Chain Ceramides and Free Fatty Acids in the Skin Epidermis, Liver, and Kidneys of db/db Mice, a Type 2 Diabetes Mellitus Model BIOMOLECULES & THERAPEUTICS, 2019, v.27 no.5, 457-465
- Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress Antioxidants and Redox Signaling, 2019, v.31 no.18, 1339-1351
- Inhibition of Karyopherin-2 Augments Radiation-Induced Cell Death by Perturbing BRCA1-Mediated DNA Repair INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.11, 2843
- Integrative omics reveals metabolic and transcriptomic alteration of nonalcoholic fatty liver disease in catalase knockout mice Biomolecules and Therapeutics, 2019, v.27 no.2, 134-144
- Network-based integrated analysis of omics data reveal novel players ofTGF-beta 1-induced EMT in human peritoneal mesothelial cells SCIENTIFIC REPORTS, 2019, v.9, 1497
- PGC-1α, a potential therapeutic target against kidney aging Aging Cell, 2019, v.18 no.5, e12994
- Peroxiredoxin 3 deficiency accelerates chronic kidney injury in mice through interactions between macrophages and tubular epithelial cells Free Radical Biology and Medicine, 2019, v.131, 162-172
- Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis Scientific Reports, 2019, v.9 no.1, 14707
- A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats PHARMACOLOGY, 2018, v.102 no.3-4, 180-189
- Carbon monoxide releasing molecule-2 protects mice against acute kidney injury through inhibition of ER stress KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2018, v.22 no.5, 567-575
- Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, v.646, 90-97
- Orally active, species-independent novel A(3) adenosine receptor antagonist protects against kidney injury in db/db mice EXPERIMENTAL AND MOLECULAR MEDICINE, 2018, v.50
- 8-Hydroxy-2-deoxyguanosine ameliorates high-fat diet-induced insulin resistance and adipocyte dysfunction in mice Biochemical and Biophysical Research Communications, 2017, v.491 no.4, 890-896
- A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis ONCOTARGET, 2017, v.8 no.43, 74217-74232
- APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury LABORATORY INVESTIGATION, 2017, v.97 no.4, 419-431
- Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of ampk autophagy American Journal of Physiology - Renal Physiology, 2017, v.312 no.2, F323-F334
- Effects of low-dose irradiation on mice with Escherichia coli-induced sepsis Toxicology and Applied Pharmacology, 2017, v.333, 17-25
- Endogenous catalase delays high-fat diet-induced liver injury in mice KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2017, v.21 no.3, 317-325
- TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease ONCOTARGET, 2017, v.8 no.52, 89746-89760
- A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice BRITISH JOURNAL OF PHARMACOLOGY, 2016, v.173 no.17, 2622-2632
- Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model PLOS ONE, 2016, v.11 no.6
- Novel Role of Endogenous Catalase in Macrophage Polarization in Adipose Tissue MEDIATORS OF INFLAMMATION, 2016, v.2016
- Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins PLOS ONE, 2015, v.10 no.11
- Short-term Treatment of Daumone Improves Hepatic Inflammation in Aged Mice KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2015, v.19 no.3, 269-274
- 18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity Molecular Nutrition and Food Research, 2014, v.58 no.7, 1436-1446
- Clinical implication of allogenic implantation of adipogenic differentiated adipose-derived stem cells Stem Cells Translational Medicine, 2014, v.3 no.11, 1312-1322
- Daumone fed late in life improves survival and reduces hepatic inflammation and fibrosis in mice Aging Cell, 2014, v.13 no.4, 709-718
- EFFECT OF BIOCOMPATIBLE PERITONEAL DIALYSIS SOLUTION ON RESIDUAL RENAL FUNCTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS PERITONEAL DIALYSIS INTERNATIONAL, 2014, v.34 no.7, 724-731
- Inhibitory role of the KEAP1-NRF2 pathway in TGFbβ1-stimulated renal epithelial transition to fibroblastic cells: A modulatory effect on SMAD signaling PLoS ONE, 2014, v.9 no.4
- Synthesis and Anti-Renal Fibrosis Activity of Conformationally Locked Truncated 2-Hexynyl-N-6-Substituted-(N)-Methanocarba-nucleosides as A(3) Adenosine Receptor Antagonists and Partial Agonists JOURNAL OF MEDICINAL CHEMISTRY, 2014, v.57 no.4, 1344-1354
- [학술지논문] Adenosine receptors as emerging therapeutic targets for diabetic kidney disease KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, v.41 no.0 , S74-S88
- [학술지논문] Kidney protective potential of lactoferrin: pharmacological insights and therapeutic advances KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2022, v.26 no.1 , 1-13
- [학술지논문] Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, v.54 no.8 , 1086-1097
- [학술지논문] Activation of beta(2) adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases ARCHIVES OF PHARMACAL RESEARCH, 2021, v.44 no.1 , 49-62
- [학술지논문] Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice BIOMOLECULES, 2021, v.11 no.2 , 322-322
- [학술지논문] CO-Releasing Molecule-2 Prevents Acute Kidney Injury through Suppression of ROS-Fyn-ER Stress Signaling in Mouse Model OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, v.2021 no.0 , 994772-994772
- [학술지논문] Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk PHYTOMEDICINE, 2021, v.80 no.0 , 153393-153393
- [학술지논문] Dual Actions of A(2A) and A(3) Adenosine Receptor Ligand Prevents Obstruction-Induced Kidney Fibrosis in Mice INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.11 , 5667-5667
- [학술지논문] Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2 CELLS, 2021, v.10 no.12 , 3306-3306
- [학술지논문] Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy KIDNEY INTERNATIONAL, 2021, v.99 no.2 , 443-455
- [학술지논문] Heukcha, naturally post-fermented green tea extract, ameliorates diet-induced hypercholesterolemia and NAFLD in hamster JOURNAL OF FOOD SCIENCE, 2021, v.86 no.11 , 5016-5025
- [학술지논문] KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in Mice BIOMOLECULES & THERAPEUTICS, 2021, v.29 no.1 , 41-51
- [학술지논문] Pharmacotherapy against Oxidative Stress in Chronic Kidney Disease: Promising Small Molecule Natural Products Targeting Nrf2-HO-1 Signaling Antioxidants, 2021, v.10 no.2 , 258-258
- [학술지논문] Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.15 , 8258-8258
- [학술지논문] Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances MARINE DRUGS, 2021, v.19 no.3 , 167-167
- [학술지논문] Protective Effects of Black Cumin (Nigella sativa) and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, v.22 no.16 , 9078-9078
- [학술지논문] Evaluation of Anti-Tumor Effects of Whole-Body Low-Dose Irradiation in Metastatic Mouse Models CANCERS, 2020, v.12 no.5 , 1126-1126
- [학술지논문] Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury BIOMOLECULES & THERAPEUTICS, 2020, v.28 no.3 , 213-221
- [학술지논문] Inhibition of Src Family Kinases Ameliorates LPS-Induced Acute Kidney Injury and Mitochondrial Dysfunction in Mice INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.21 , 8246-8246
- [학술지논문] Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways FRONTIERS IN PHARMACOLOGY, 2020, v.11 no.0 , 265-265
- [학술지논문] The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress FREE RADICAL BIOLOGY AND MEDICINE, 2020, v.148 no.0 , 22-32
- [학술지논문] Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.23 , 8969-8969
- [학술지논문] Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2019, v.471 no.6 , 829-843
- [학술지논문] Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-beta and NLRP3 inflammasome signaling pathway CELL DEATH & DISEASE, 2019, v.10 no.0 , 78-78
- [학술지논문] Cigarette smoke inhalation aggravates diabetic kidney injury in rats TOXICOLOGY RESEARCH, 2019, v.8 no.6 , 964-971
- [학술지논문] Correlation study between A(3) adenosine receptor binding affinity and anti-renal interstitial fibrosis activity of truncated adenosine derivatives ARCHIVES OF PHARMACAL RESEARCH, 2019, v.42 no.9 , 773-779
- [학술지논문] Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress ANTIOXIDANTS & REDOX SIGNALING, 2019, v.31 no.18 , 1339-1351
- [학술지논문] Inhibition of Karyopherin-α2 Augments Radiation-Induced Cell Death by Perturbing BRCA1-Mediated DNA Repair INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, v.20 no.11 , 2843-2843
- [학술지논문] Integrative Omics Reveals Metabolic and Transcriptomic Alteration of Nonalcoholic Fatty Liver Disease in Catalase Knockout Mice BIOMOLECULES & THERAPEUTICS, 2019, v.27 no.2 , 1-11
- [학술지논문] Network-based integrated analysis of omics data reveal novel players ofTGF-beta 1-induced EMT in human peritoneal mesothelial cells SCIENTIFIC REPORTS, 2019, v.9 no.0 , 1497-1497
- [학술지논문] PGC-1 alpha, a potential therapeutic target against kidney aging Aging Cell, 2019, v.18 no.5 , 12994-12994
- [학술지논문] Peroxiredoxin 3 deficiency accelerates chronic kidney injury in mice through interactions between macrophages and tubular epithelial cells FREE RADICAL BIOLOGY AND MEDICINE, 2019, v.131 no.0 , 162-172
- [학술지논문] Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis SCIENTIFIC REPORTS, 2019, v.9 no.0 , 14707-14707
Courses
-
2022-2nd
-
Pharmacology Ⅱ
- Subject No 37129Class No 01
- 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A400) , Thu 4~4 (PHM-A404)
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 02
- 4Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A400) , Thu 3~3 (PHM-A404)
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 03
- 4Year ( 3Credit , 3Hour) Tue 4~4 (PHM-A400) , Thu 6~6 (PHM-A404)
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 04
- 4Year ( 3Credit , 3Hour) Tue 4~4 (PHM-A400) , Thu 6~6 (PHM-A404)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 02
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 04
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A313)
- Major Requisite
-
Lab rotation Ⅰ
- Subject No 38927Class No 01
- 1Year ( 1.5Credit , 0Hour) Thu 7~7
-
Lab rotation Ⅰ
- Subject No 38927Class No 02
- 1Year ( 1.5Credit Thu 7~7
-
Lab rotation Ⅰ
- Subject No 39032Class No 01
- 1Year ( 1.5Credit , 0Hour) Thu 7~7
-
Targeted Pharmacology
- Subject No G16895Class No 01
- Year ( 3Credit , 3Hour) Thu 2~3 (PHM-A-204)
- Classroom Changed
-
-
2022-1st
-
First-Year Seminar
- Subject No 11401Class No 01
- 1Year ( 1Credit Mon 7~7
-
Pharmacology I
- Subject No 22488Class No 01
- 4Year ( 3Credit , 3Hour) Tue 2~2 (PHM-A104) , Fri 6~6 (PHM-A404)
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 02
- 4Year ( 3Credit , 3Hour) Tue 3~3 (PHM-A104) , Fri 3~3 (PHM-A400)
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 03
- 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A404) , Fri 5~5 (PHM-A404)
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 04
- 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A404) , Fri 5~5 (PHM-A404)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 02
- 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 03
- 5Year ( 1.5Credit , 3Hour) Thu 6~7 (PHM-A313)
- Major Requisite
-
Principles of Pharmacology
- Subject No G16906Class No 01
- Year ( 3Credit , 3Hour) Thu 2~3 (-)
-
-
2021-2nd
-
Pharmacology Ⅱ
- Subject No 37129Class No 01
- 4Year ( 3Credit , 3Hour) Tue 5~5 , Thu 4~4
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 02
- 4Year ( 3Credit , 3Hour) Mon 4~4 , Thu 3~3
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 03
- 4Year ( 3Credit , 3Hour) Mon 5~5 , Tue 4~4
- Major Requisite
-
Pharmacology Ⅱ
- Subject No 37129Class No 04
- 4Year ( 3Credit , 3Hour) Mon 5~5 , Tue 4~4
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 01
- 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 02
- 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A313)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅱ
- Subject No 37155Class No 02
- 6Year ( 4Credit
- Major Requisite
-
Targeted Pharmacology
- Subject No G16895Class No 01
- Year ( 3Credit , 3Hour) Wed 2~3 (PHM-)
-
-
2021-1st
-
Pharmacology I
- Subject No 22488Class No 01
- 4Year ( 3Credit , 3Hour) Mon 5~5 , Wed 2~2
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 02
- 4Year ( 3Credit , 3Hour) Mon 3~3 , Wed 3~3
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 03
- 4Year ( 3Credit , 3Hour) Mon 2~2 , Wed 4~4
- Major Requisite
-
Pharmacology I
- Subject No 22488Class No 04
- 4Year ( 3Credit , 3Hour) Mon 2~2 , Wed 4~4
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 01
- 5Year ( 1.5Credit , 3Hour) Thu 5~6 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 02
- 5Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A313)
- Major Requisite
-
Pharmaceutical Experiment Laboratory V
- Subject No 37137Class No 03
- 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A313)
- Major Requisite
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Principles of Pharmacology
- Subject No G16906Class No 01
- Year ( 3Credit , 3Hour) Tue 2~3 (PHM-)
-
Academic Background
Ewha Womans University 약학사(약학대학)